Novavax (NVAX) Other Non Operating Income (2016 - 2025)
Novavax has reported Other Non Operating Income over the past 14 years, most recently at -$59.8 million for Q4 2025.
- Quarterly results put Other Non Operating Income at -$59.8 million for Q4 2025, down 119.17% from a year ago — trailing twelve months through Dec 2025 was -$28.7 million (down 80.34% YoY), and the annual figure for FY2025 was -$28.7 million, changed.
- Other Non Operating Income for Q4 2025 was -$59.8 million at Novavax, down from $9.2 million in the prior quarter.
- Over the last five years, Other Non Operating Income for NVAX hit a ceiling of $64.0 million in Q4 2022 and a floor of -$59.8 million in Q4 2025.
- Median Other Non Operating Income over the past 5 years was $1.7 million (2022), compared with a mean of -$2.1 million.
- Peak annual rise in Other Non Operating Income hit 14639.86% in 2022, while the deepest fall reached 756.31% in 2022.
- Novavax's Other Non Operating Income stood at $434000.0 in 2021, then soared by 14639.86% to $64.0 million in 2022, then plummeted by 142.07% to -$26.9 million in 2023, then fell by 1.47% to -$27.3 million in 2024, then plummeted by 119.17% to -$59.8 million in 2025.
- The last three reported values for Other Non Operating Income were -$59.8 million (Q4 2025), $9.2 million (Q3 2025), and $11.9 million (Q2 2025) per Business Quant data.